BMC Cancer
- CHEN W, Yan L, Li Q, Zhou S, et al
Molecular subtype of ovarian clear cell carcinoma: an analysis of 80 Chinese
patients using the TCGA molecular classification of endometrial cancer.
BMC Cancer. 2025;25:90.
Cancer
- LIU YL, Mathews CA, Simpkins F, Cadoo KA, et al
Olaparib as treatment for platinum-sensitive relapsed ovarian cancer by BRCA
mutation and homologous recombination deficiency: Phase 2 LIGHT study final
overall survival analysis.
Cancer. 2025;131:e35707.
Eur J Obstet Gynecol Reprod Biol
- NAKAMURA K, Ida N, Hirasawa A, Okamoto K, et al
CD63 as a potential biomarker for patients with ovarian cancer.
Eur J Obstet Gynecol Reprod Biol. 2025;306:87-93.
Int J Gynaecol Obstet
- KANG J, Mei D, Xing X, Cao Y, et al
Characteristics and prognostic implications of a cohort of 50 Sertoli-Leydig cell
tumors at a single center.
Int J Gynaecol Obstet. 2025;168:613-619.
- NIE X, Xu T, Cheng W
Comparative prognosis analysis of ovarian squamous cell carcinoma versus serous
carcinoma: Insights from the SEER database.
Int J Gynaecol Obstet. 2024 Sep 11. doi: 10.1002/ijgo.15899.
Mol Ther Oncol
- MATTHEWS B, Wong-Brown M, Liu D, Yee C, et al
Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz
in high-grade serous ovarian cancer.
Mol Ther Oncol. 2024;32:200911.
PLoS One
- TJOKROPRAWIRO BA, Novitasari K, Ulhaq RA, Sulistya HA, et al
Investigation of the trends and associated factors of ovarian cancer in
Indonesia: A systematic analysis of the Global Burden of Disease study 1990-2021.
PLoS One. 2025;20:e0313418.
- TAL O, Zahavi T, Sinberger LA, Salmon-Divon M, et al
Unlocking prognostic potential: A genomic signature of caloric restriction in
patients with epithelial ovarian cancer.
PLoS One. 2025;20:e0317502.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016